Literature DB >> 33454843

Cannabinoid type 1 receptors in A2a neurons contribute to cocaine-environment association.

Brandon D Turner1, Nicholas K Smith1, Kevin M Manz1,2,3, Betty T Chang1, Eric Delpire1,3,4, Carrie A Grueter1,3, Brad A Grueter5,6,7,8,9.   

Abstract

RATIONALE: Cannabinoid type 1 receptors (CB1Rs) are widely expressed within the brain's reward circuits and are implicated in regulating drug induced behavioral adaptations. Understanding how CB1R signaling in discrete circuits and cell types contributes to drug-related behavior provides further insight into the pathology of substance use disorders. OBJECTIVE AND METHODS: We sought to determine how cell type-specific expression of CB1Rs within striatal circuits contributes to cocaine-induced behavioral plasticity, hypothesizing that CB1R function in distinct striatal neuron populations would differentially impact behavioral outcomes. We crossed conditional Cnr1fl/fl mice and striatal output pathway cre lines (Drd1a -cre; D1, Adora2a -cre; A2a) to generate cell type-specific CB1R knockout mice and assessed their performance in cocaine locomotor and associative behavioral assays.
RESULTS: Both knockout lines retained typical locomotor activity at baseline. D1-Cre x Cnr1fl/fl mice did not display hyperlocomotion in response to acute cocaine dosing, and both knockout lines exhibited blunted locomotor activity across repeated cocaine doses. A2a-cre Cnr1fl/fl, mice did not express a preference for cocaine paired environments in a two-choice place preference task.
CONCLUSIONS: This study aids in mapping CB1R-dependent cocaine-induced behavioral adaptations onto distinct striatal neuron subtypes. A reduction of cocaine-induced locomotor activation in the D1- and A2a-Cnr1 knockout mice supports a role for CB1R function in the motor circuit. Furthermore, a lack of preference for cocaine-associated context in A2a-Cnr1 mice suggests that CB1Rs on A2a-neuron inhibitory terminals are necessary for either reward perception, memory consolidation, or recall. These results direct future investigations into CB1R-dependent adaptations underlying the development and persistence of substance use disorders.

Entities:  

Keywords:  Cannabinoid receptor; Cocaine; Striatum

Mesh:

Substances:

Year:  2021        PMID: 33454843      PMCID: PMC8386588          DOI: 10.1007/s00213-021-05759-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  68 in total

Review 1.  Sex Differences in Animal Models: Focus on Addiction.

Authors:  Jill B Becker; George F Koob
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

2.  RGS4 is required for dopaminergic control of striatal LTD and susceptibility to parkinsonian motor deficits.

Authors:  Talia N Lerner; Anatol C Kreitzer
Journal:  Neuron       Date:  2012-01-26       Impact factor: 17.173

3.  Sex Differences in Value-Based Decision Making Underlie Substance Use Disorders in Females.

Authors:  Jennifer E Zachry; Amy R Johnson; Erin S Calipari
Journal:  Alcohol Alcohol       Date:  2019-07-01       Impact factor: 2.826

4.  Changes in endocannabinoid and N-acylethanolamine levels in rat brain structures following cocaine self-administration and extinction training.

Authors:  Beata Bystrowska; Irena Smaga; Małgorzata Frankowska; Małgorzata Filip
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-12-12       Impact factor: 5.067

5.  mGlu1 and mGlu5 modulate distinct excitatory inputs to the nucleus accumbens shell.

Authors:  Brandon D Turner; Jerri M Rook; Craig W Lindsley; P Jeffrey Conn; Brad A Grueter
Journal:  Neuropsychopharmacology       Date:  2018-03-27       Impact factor: 7.853

6.  Cannabinoid receptor 1-expressing neurons in the nucleus accumbens.

Authors:  Bradley D Winters; Juliane M Krüger; Xiaojie Huang; Zachary R Gallaher; Masago Ishikawa; Krzysztof Czaja; James M Krueger; Yanhua H Huang; Oliver M Schlüter; Yan Dong
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-10       Impact factor: 11.205

7.  Intra-accumbens rimonabant is rewarding but induces aversion to cocaine in cocaine-treated rats, as does in vivo accumbal cannabinoid CB1 receptor silencing: critical role for glutamate receptors.

Authors:  S Ramiro-Fuentes; O Ortiz; R Moratalla; E Fernandez-Espejo
Journal:  Neuroscience       Date:  2010-02-16       Impact factor: 3.590

Review 8.  Striatal plasticity and basal ganglia circuit function.

Authors:  Anatol C Kreitzer; Robert C Malenka
Journal:  Neuron       Date:  2008-11-26       Impact factor: 17.173

Review 9.  Drug Addiction: Updating Actions to Habits to Compulsions Ten Years On.

Authors:  Barry J Everitt; Trevor W Robbins
Journal:  Annu Rev Psychol       Date:  2015-08-07       Impact factor: 24.137

10.  The striatal balancing act in drug addiction: distinct roles of direct and indirect pathway medium spiny neurons.

Authors:  Mary Kay Lobo; Eric J Nestler
Journal:  Front Neuroanat       Date:  2011-07-18       Impact factor: 3.856

View more
  3 in total

1.  Hippocampal Cannabinoid 1 Receptors Are Modulated Following Cocaine Self-administration in Male Rats.

Authors:  David De Sa Nogueira; Romain Bourdy; Rafael Alcala-Vida; Dominique Filliol; Virginie Andry; Yannick Goumon; Jean Zwiller; Pascal Romieu; Karine Merienne; Mary C Olmstead; Katia Befort
Journal:  Mol Neurobiol       Date:  2022-01-15       Impact factor: 5.590

Review 2.  Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders.

Authors:  Daniela Navarro; Ani Gasparyan; Francisco Navarrete; Abraham B Torregrosa; Gabriel Rubio; Marta Marín-Mayor; Gabriela B Acosta; Maria Salud Garcia-Gutiérrez; Jorge Manzanares
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

3.  Control of exploration, motor coordination and amphetamine sensitization by cannabinoid CB1 receptors expressed in medium spiny neurons.

Authors:  Alipi V Bonm; Izaskun Elezgarai; Christina M Gremel; Katie Viray; Nigel S Bamford; Richard D Palmiter; Pedro Grandes; David M Lovinger; Nephi Stella
Journal:  Eur J Neurosci       Date:  2021-07-13       Impact factor: 3.698

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.